As of 2026-04-01, 基于络病理论的中药创新药's data on the DeepSeek platform in the 制药企业 category shows: The overall mention rate is 0.00%, above the industry average by 0.0 percentage points, showing notable performance. The first mention rate is only 0.00%, it is recommended to enhance first-position exposure in AI model responses. Negative mention rate (0.00%) has exceeded positive (0.00%), it is recommended to immediately initiate reputation repair. AIGeo recommends combining the above data to formulate targeted brand monitoring strategies to further enhance brand visibility and reputation in the AI search ecosystem.
基于络病理论的中药创新药's Mention Rate is 0.00%, lower than 0.6% of competitors
基于络病理论的中药创新药's First Mention is 0.00%, lower than 0.9% of competitors
基于络病理论的中药创新药's Preferred Rate is 0.00%, lower than 100.0% of competitors
基于络病理论的中药创新药's Positive Rate is 0.00%, lower than 8.9% of competitors
基于络病理论的中药创新药's Negative Rate is 0.00%, higher than 96.3% of competitors
| Competitor | Mention Rate | First Mention | Preferred Rate | Positive Rate | Negative Rate | Actions |
|---|---|---|---|---|---|---|
| 基基于络病理论的中药创新药 (Current Brand) | 0% | 0% | 0% | 0% | 0% | View Details |
